Pfizer and Global Blood Therapeutics have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing...

View the Online Magazine

Launches

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Beckman Coulter, a global clinical diagnostics leader, has announced a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood...

The green solution to wastewater sterilisation is black and white

The need to add chemical disinfectants to discarded liquids and wastewater may now be over, due to AstellBio’s new range of thermal Effluent Decontamination...

Beckman Coulter introduces antipsychotic drug testing to address unmet clinical need for more than 69m people living with serious mental conditions

Beckman Coulter, a global clinical diagnostics leader, will introduce new antipsychotic drug tests to laboratories and clinicians to address an unmet clinical need for...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Shionogi signs agreement with NHS England to begin innovative subscription payment model for reimbursement of its antibiotic, Fetcroja (Cefiderocol)

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V. (hereafter "Shionogi"), today announced that Shionogi B.V. had signed an agreement with NHS England...

Lupin Healthcare announces availability of the first carbon neutral pMDI with Luforbec® 100/6 (beclometasone 100 mcg / formoterol 6 mcg) and establishes commitment to...

Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin), has announced that Luforbec (beclomethasone / formoterol) 100/6 pressurised metered dose inhaler (pMDI)...

WHO recommends successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator

WHO has made a strong recommendation for nirmatrelvir and ritonavir, sold under the name Paxlovid, for mild and moderate COVID-19 patients at highest risk...

LogiPharma leads the way as Tower takes cold chain containers on the road

In its first appearance at the renowned LogiPharma conference, Tower Cold Chain is speaking about the key challenges in temperature-controlled logistics, as well as...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Poseida Therapeutics to collaborate with Roche to develop allogeneic CAR-T cell therapies for hematologic malignancies

Poseida Therapeutics has entered into a broad strategic collaboration and license agreement with Roche, focused on developing allogeneic CAR-T therapies directed to hematologic malignancies. The...

QUANTRO Therapeutics collaborates with Boehringer Ingelheim to develop drug candidates interfering with transcriptional regulators

QUANTRO Therapeutics have entered a three-year collaboration, option and license agreement with Boehringer Ingelheim for the identification and development of inhibitors for up to...

University of Birmingham signs licensing deal with world’s largest COVID-19 test provider to commercialise novel testing method

A unique testing method invented at the University of Birmingham (UK) is set for a global rollout after its commercial rights were exclusively licensed...

NIH and GreenLight Biosciences to collaborate on COVID-19 vaccine development for new variants

GreenLight Biosciences is collaborating with the National Institutes of Health (NIH) to develop COVID-19 vaccines that are more broadly protective against new variants and...

Ipsen and Marengo Therapeutics announce strategic partnership to advance two precision immuno-oncology candidates into the clinic

Ipsen and Marengo Therapeutics have formed a strategic partnership to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic. The collaboration will...

Appointments